ReviewOncology research and treatment2024

Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates.

Patrick Schöffski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.